ID | 66030 |
FullText URL | |
Author |
Uka, Mayu
Department of Radiology, Dentistry and Pharmaceutical Science, Okayama University Graduate School of Medicine
Iguchi, Toshihiro
Department of Radiology, Dentistry and Pharmaceutical Science, Okayama University Graduate School of Medicine
Kaken ID
Okawa, Nanako
Department of Radiology, Dentistry and Pharmaceutical Science, Okayama University Graduate School of Medicine
Matsui, Yusuke
Department of Radiology, Dentistry and Pharmaceutical Science, Okayama University Graduate School of Medicine
Tomita, Koji
Department of Radiology, Dentistry and Pharmaceutical Science, Okayama University Graduate School of Medicine
Umakoshi, Noriyuki
Department of Radiology, Dentistry and Pharmaceutical Science, Okayama University Graduate School of Medicine
Munetomo, Kazuaki
Department of Radiology, Dentistry and Pharmaceutical Science, Okayama University Graduate School of Medicine
Gobara, Hideo
Division of Medical Informatics, Okayama University Hospital
ORCID
Kaken ID
publons
researchmap
Araki, Motoo
Department of Urology, Dentistry and Pharmaceutical Science, Okayama University Graduate School of Medicine
ORCID
Kaken ID
publons
researchmap
Hiraki, Takao
Department of Radiology, Dentistry and Pharmaceutical Science, Okayama University Graduate School of Medicine
Kaken ID
publons
researchmap
|
Abstract | Purpose To retrospectively assess the feasibility, safety, renal function, technique efficacy rate, and survival of patients with clinical T3a renal cell carcinoma (RCC).
Materials and methods Sixteen cryoablation sessions were performed in 14 patients (10 men; mean age, 69.8 ± 10.5 years; range, 49–90 years) with 14 clear cell T3a RCCs (mean, 3.3 ± 0.9 cm; range, 1.9–5.2 cm). One patient was on dialysis. Transcatheter arterial embolization was performed before cryoablation in 15 sessions. The primary endpoint was the technique efficacy rate. The secondary endpoints included feasibility, safety, renal function, and survival. Results Cryoablation was technically successful in all RCC cases. In two RCCs, cryoablation was performed twice because of local tumor progression. No major adverse events were observed. All patients were alive without metastases, with a median follow-up of 45 months (6−93 months). Complete response was achieved by cryoablation in 11 RCCs (78.6%). The primary and secondary technique efficacy rates were 77.1% and 84.4% at 1 year, 57.9% and 73.9% at 3 years, and 57.9% and 73.9% at 5 years, respectively. One patient underwent dialysis given a total contralateral nephrectomy due to another RCC 1 month after initial cryoablation and a total ipsilateral nephrectomy 46 months after initial cryoablation due to local progression. Except for two dialysis patients, of the 12 patients with a median follow-up of 41 months (6–93 months), none were on dialysis. Conclusion Cryoablation was safe and effective in T3a RCC, which mainly involved the renal venous branches and may represent an alternative treatment for inoperable patients. |
Keywords | Kidney neoplasms
Cryosurgery
Image-guided
|
Note | The version of record of this article, first published in Japanese Journal of Radiology, is available online at Publisher’s website: http://dx.doi.org/10.1007/s11604-022-01297-8
|
Published Date | 2022-06-21
|
Publication Title |
Japanese Journal of Radiology
|
Volume | volume40
|
Issue | issue11
|
Publisher | Springer Science and Business Media LLC
|
Start Page | 1201
|
End Page | 1209
|
ISSN | 1867-1071
|
NCID | AA12375935
|
Content Type |
Journal Article
|
language |
English
|
OAI-PMH Set |
岡山大学
|
Copyright Holders | © The Author(s) 2022
|
File Version | publisher
|
PubMed ID | |
DOI | |
Web of Science KeyUT | |
Related Url | isVersionOf https://doi.org/10.1007/s11604-022-01297-8
|
License | http://creativecommons.org/licenses/by/4.0/
|
Citation | Uka, M., Iguchi, T., Okawa, N. et al. Percutaneous cryoablation for clinical T3a renal cell carcinoma (< 7 cm) with segmental vein involvement or perinephric fat invasion based on preoperative evaluation of high-resolution multidetector computed tomography scan. Jpn J Radiol 40, 1201–1209 (2022). https://doi.org/10.1007/s11604-022-01297-8
|